Publication

Efficacy and Safety of Lersivirine (UK-453,061) versus Efavirenz in Antiretroviral Treatment-Naïve HIV-1-Infected Patients: Week 48 Primary Analysis Results from an Ongoing, Multicenter, Randomized, Double-Blind, Phase IIb Trial

Journal Paper/Review - Oct 31, 2012

Vernazza Pietro, Craig Charles, Mori Julie, Goodrich James, Valdez Hernan, Lazzarin Adriano, Kaplan Richard, Cooper David A, Pulik Piotr, Weil Elizabeth, Pozniak Anton, Wang Cunshan, Tawadrous Margaret